pdufa.bio

Balstilimab

Page updated ·next FDA decision on the calendar ·Data as of Nov 5, 2026 9:00 PM ET

Balstilimab is an Agenus Inc program. Its next catalyst is a Readout in Dec 2026. Every date links its source.

AGEN catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Agenus Inc (AGEN). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Dec 2026AGEN

Questions

When is Balstilimab's next FDA decision or readout?

The next tracked catalyst for Balstilimab is a Readout in Dec 2026.

What happened at Balstilimab's most recent FDA decision?

No FDA decision for Balstilimab is in our archive yet.

Who makes Balstilimab?

Agenus Inc (AGEN).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.